5-HTTLPR不会缓解注意力偏差修改对抑郁症的影响:一项随机化模拟对照试验
Ragnhild Bø1, Rune Jonassen2, Catherine J Harmer3,4
1Clinical Neuroscience Research Group, Department of Psychology, University of Oslo, Oslo, Norway. ragnhild.bo@psykologi.uio.no.
Translational psychiatry
|October 6, 2025
概括
胺转运基因 (SLC6A4) 5-HTTLPR多态性并没有适度注意力偏差修改 (ABM) 对残留抑郁症状的有效性. 个性化抑郁症治疗可能需要考虑基因相互作用.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 精神病学是一个精神病学.
背景情况:
- 在血清素输送基因 (SLC6A4) 中的5-HTTLPR多态是可塑性标记物.
- 在5-HTTLPR中,一个特定的SNP (rs25531) 影响SLC6A4转录,影响突触性血清素载体的可用性.
- 5-HTTLPR与注意偏差及其可修改性有关,这表明它可能在缓解抑郁症治疗结果方面发挥作用.
研究的目的:
- 调查5-HTTLPR多态体内的rs25531变体是否会缓和注意力偏差修改 (ABM) 的有效性.
- 评估ABM对抑郁症,焦虑症和注意力偏差对残留重大抑郁症 (MDD) 症状的个体的影响,按基因型分层.
主要方法:
- 一个注册的随机化模拟受控试验,涉及301名残留MDD症状的参与者.
- 参与者每天在家接受14天的ABM或假干预.
- 对264名参与者进行了SLC6A4 (rs25531) 的基因分析,以确定基因型.
主要成果:
- 对于rs25531等位变异在抑郁症 (HDRS,BDI-II),焦虑症 (BAI) 症状得分或干预后注意力偏差方面没有发现显著的适度效应.
- 在这个样本中,5-HTTLPR多态性没有影响ABM的有效性.
结论:
- 研究的5-HTTLPR多态性 (rs25531) 似乎没有缓解对残留抑郁症状的注意偏差修改结果.
- 未来针对抑郁症的个性化干预可能需要探索复杂的基因相互作用,而不是单个多态.
更多相关视频
07:12Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
Published on: August 2, 2021
4.1K
13:20Online Repetitive Transcranial Magnetic Stimulation of Dorsomedial and Dorsolateral Prefrontal Cortex in Cognition Decision Making, and Cognitive Dissonance
Published on: December 5, 2025
645
相关概念视频
01:54The Placebo Effect
6.8K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.8K
02:07Blind Procedures
12.9K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
12.9K
01:11Blinding
3.8K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
3.8K
01:23Antidepressant Drugs: MAOIs and Other Agents
823
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
823